These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17964953)

  • 1. Molecular modeling of the cytoskeleton.
    Zheng X; Sept D
    Methods Cell Biol; 2008; 84():893-910. PubMed ID: 17964953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds.
    Srivani P; Sastry GN
    J Mol Graph Model; 2009 Feb; 27(6):676-88. PubMed ID: 19147382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
    Cherkasov A; Ban F; Santos-Filho O; Thorsteinson N; Fallahi M; Hammond GL
    J Med Chem; 2008 Apr; 51(7):2047-56. PubMed ID: 18330978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational biology: Biosensor design.
    DeGrado WF
    Nature; 2003 May; 423(6936):132-3. PubMed ID: 12736670
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative structure-activity relationship models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the human ether-a-go-go-related gene potassium channel inhibition.
    Coi A; Massarelli I; Saraceno M; Carli N; Testai L; Calderone V; Bianucci AM
    Chem Biol Drug Des; 2009 Oct; 74(4):416-33. PubMed ID: 19751420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MADAMM: a multistaged docking with an automated molecular modeling protocol.
    Cerqueira NM; Bras NF; Fernandes PA; Ramos MJ
    Proteins; 2009 Jan; 74(1):192-206. PubMed ID: 18618708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First CoMFA characterization of vesamicol analogs as ligands for the vesicular acetylcholine transporter.
    Szymoszek A; Wenzel B; Scheunemann M; Steinbach J; Schüürmann G
    J Med Chem; 2008 Apr; 51(7):2128-36. PubMed ID: 18324757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
    Vaidya M; Weigt M; Wiese M
    Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
    Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
    J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.
    Durdagi S; Papadopoulos MG; Papahatjis DP; Mavromoustakos T
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6754-63. PubMed ID: 17980589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.
    Rastelli G; Degliesposti G; Del Rio A; Sgobba M
    Chem Biol Drug Des; 2009 Mar; 73(3):283-6. PubMed ID: 19207463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the binding modes between BB-83698 and peptide deformylase from Bacillus stearothermophilus by docking and molecular dynamics simulation.
    Wang Q; Wang J; Cai Z; Xu W
    Biophys Chem; 2008 May; 134(3):178-84. PubMed ID: 18321635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional quantitative structure-activity relationship modeling of gamma-secretase inhibitors using molecular field analysis.
    Sammi T; Silakari O; Ravikumar M
    Chem Biol Drug Des; 2008 Feb; 71(2):155-66. PubMed ID: 18221306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.
    Tintori C; Magnani M; Schenone S; Botta M
    Eur J Med Chem; 2009 Mar; 44(3):990-1000. PubMed ID: 18722033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of anthropogenic chemicals as ligands of zebrafish sex hormone binding globulin.
    Thorsteinson N; Ban F; Santos-Filho O; Tabaei SM; Miguel-Queralt S; Underhill C; Cherkasov A; Hammond GL
    Toxicol Appl Pharmacol; 2009 Jan; 234(1):47-57. PubMed ID: 18725242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
    Pinheiro JR; Bitencourt M; da Cunha EF; Ramalho TC; Freitas MP
    Bioorg Med Chem; 2008 Feb; 16(4):1683-90. PubMed ID: 18053727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins.
    Samorì C; Guerrini A; Varchi G; Fontana G; Bombardelli E; Tinelli S; Beretta GL; Basili S; Moro S; Zunino F; Battaglia A
    J Med Chem; 2009 Feb; 52(4):1029-39. PubMed ID: 19530720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.